Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 279 | 3 | ANGIOGENESIS//LYMPHANGIOGENESIS//VEGF | 43269 |
| 1176 | 2 | RESTENOSIS//SMOOTH MUSCLE CELLS//INTIMAL HYPERPLASIA | 9742 |
| 22647 | 1 | TRANSCRIPTION FACTOR DECOY//DECOY//DECOY OLIGODEOXYNUCLEOTIDE | 396 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TRANSCRIPTION FACTOR DECOY | authKW | 1100559 | 6% | 63% | 22 |
| 2 | DECOY | authKW | 838805 | 10% | 28% | 38 |
| 3 | DECOY OLIGODEOXYNUCLEOTIDE | authKW | 481492 | 3% | 55% | 11 |
| 4 | NF KAPPA B DECOY | authKW | 339283 | 2% | 47% | 9 |
| 5 | GENE THER Y SCI | address | 327098 | 10% | 11% | 39 |
| 6 | HVJ LIPOSOME | authKW | 279508 | 3% | 29% | 12 |
| 7 | PNA DNA CHIMERAS | authKW | 259977 | 2% | 47% | 7 |
| 8 | CLIN GENE THER Y MED | address | 238761 | 1% | 100% | 3 |
| 9 | OLIGONUCLEOTIDE DECOY | authKW | 238761 | 1% | 100% | 3 |
| 10 | TRANSCRIPTION FACTOR DECOY TFD | authKW | 238761 | 1% | 100% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Urology & Nephrology | 1517 | 18% | 0% | 73 |
| 2 | Medicine, Research & Experimental | 801 | 18% | 0% | 70 |
| 3 | Biotechnology & Applied Microbiology | 434 | 15% | 0% | 60 |
| 4 | Genetics & Heredity | 302 | 13% | 0% | 50 |
| 5 | Biochemistry & Molecular Biology | 291 | 26% | 0% | 101 |
| 6 | Transplantation | 108 | 4% | 0% | 15 |
| 7 | Pharmacology & Pharmacy | 99 | 12% | 0% | 46 |
| 8 | Biophysics | 61 | 6% | 0% | 22 |
| 9 | Cell Biology | 51 | 8% | 0% | 31 |
| 10 | Peripheral Vascular Diseases | 50 | 4% | 0% | 16 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GENE THER Y SCI | 327098 | 10% | 11% | 39 |
| 2 | CLIN GENE THER Y MED | 238761 | 1% | 100% | 3 |
| 3 | CLIN GENE THER Y | 148114 | 6% | 8% | 22 |
| 4 | THER IE CELLULAIRE MOL | 106115 | 1% | 67% | 2 |
| 5 | KOREAN MINIST SCI TECHNOL | 89532 | 1% | 38% | 3 |
| 6 | ANIM TRANSGEN MOL IMMUNOL | 79587 | 0% | 100% | 1 |
| 7 | CLEVELAND VET AFFAIR MED | 79587 | 0% | 100% | 1 |
| 8 | DEV PHARMACOL PHARMACOGEN TREATMENT THALASS | 79587 | 0% | 100% | 1 |
| 9 | DEV PHARMACOL PHARMACOGENOM TREATMENT THALA | 79587 | 0% | 100% | 1 |
| 10 | DIPARTIMENTO BIOMED TER IE AVANZATE | 79587 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EXPERIMENTAL NEPHROLOGY | 32470 | 4% | 3% | 15 |
| 2 | GENE THERAPY | 11552 | 6% | 1% | 24 |
| 3 | MINERVA BIOTECNOLOGICA | 5255 | 2% | 1% | 6 |
| 4 | JOURNAL OF GENE MEDICINE | 4471 | 2% | 1% | 9 |
| 5 | CURRENT DRUG TARGETS | 3321 | 2% | 0% | 9 |
| 6 | CONTRIBUTIONS TO NEPHROLOGY | 2484 | 2% | 0% | 7 |
| 7 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 1451 | 1% | 0% | 4 |
| 8 | CURRENT GENE THERAPY | 1238 | 1% | 1% | 3 |
| 9 | KIDNEY INTERNATIONAL | 1203 | 4% | 0% | 15 |
| 10 | SEMINARS IN NEPHROLOGY | 1010 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |